USPTO serial 79278076
CLARO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 15, 2022
- Examiner
- KAJUBI, ELIZABETH N
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CLARO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bradley M. Stohry
Bradley M. Stohry Reichel Stohry Dean LLP6931 Central AveIndianapolis, IN 46202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Industrial chemicals; Protein in raw material form for scientific and medical research, not intended for diagnostic or therapeutic use, nor administration to animals or humans; Gelatine for industrial purposes in the nature of gelatinous spongy chunks, powders, beads, granulates, gels, and hydrogels; Collagen for industrial purposes; peptides for industrial purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; chemicals for use in biotechnological product development; biological preparations, other than for medical or veterinary purposes, for use in industry and science; biological preparation for use in cell cultures, other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; chemical preparations used in the manufacture of engineered living tissue; chemical preparations used in the manufacture of scaffolds for tissue engineering; biopolymers used in the manufacture of engineered living tissue; biological preparations used in the manufacture of engineered living tissue; Chemicals for use in the production of inks for 3d printing, namely chemical ingredients for use in the manufacture of bio-inks; chemicals for use in the production of biological inks for 3d printing; Chemical preparations, namely preparations consisting of a mixture of gelling agents, proteins, gelatines, peptides, collagen, biopolymers, collagen hydrolysates, moistening agents, additives and preservatives, for use in 3d bioprinting of tissues and organs, not intended for diagnostic or therapeutic use; Biological preparations, namely, preparations consisting of a mixture of gelling agents, proteins, gelatines, peptides, collagen, biopolymers, collagen hydrolysates, moistening agents, additives and preservatives, for use in 3d bioprinting of tissues and organs, not intended for diagnostic or therapeutic use; biological tissue specimens for use in scientific research, not intended for diagnostic or therapeutic use | ACTIVE | — |
| 002 | Printing compositions, namely printers' pastes, ink, thinners, thickeners, coatings, preservatives and colorants; Ink for bioprinting namely printers' pastes, ink, thinners, thickeners, coatings, preservatives and colorants; Bio-ink for 3D bioprinting namely ink, thinners, thickeners, coatings, preservatives and colorants; Ink cartridges for 3D printers, filled with bio-ink consisting of a mixture of ink, thinners, thickeners, coatings, preservatives and colorants; Bio-ink consisting of a mixture of namely ink, thinners, thickeners, coatings, preservatives and colorants used in the manufacture of living tissue | ACTIVE | — |
| 005 | Chemical preparations for medical purposes, namely, bio-inks for the engineering of biological tissues for medical and veterinary purposes; Biological preparations for medical purposes, namely bio-inks for the creation of epithelial, connective, muscular and nervous tissues; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Cultures of microorganisms for medical or veterinary use; Engineered surgical transplants in the nature of implants consisting of living tissues; Transplants, namely implants comprising living tissues; Natural biomaterials for augmentation or subsequent implantation of bone and tissue for medical purposes | ACTIVE | — |
| 010 | Artificial biomaterials for manufacturing of bone and tissue for medical purposes, namely artificial bones and artificial epithelial, connective, muscular and nervous tissues for implantation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TESSENDERLO GROUP N.V.
- Other trademarks owned by TESSENDERLO GROUP N.V.
- Other trademarks owned by TESSENDERLO GROUP N.V.
- Other trademarks in Class 001
- Other trademarks in Class 002
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named CLARO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 9, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 20, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 20, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 15, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 15, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 5, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 30, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 30, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 10, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 10, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 10, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 22, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 22, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 22, 2021 | ALIE | ASSIGNED TO LIE | — |
| Sep 16, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 24, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 7, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 7, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 25, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 27, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 27, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 27, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 3, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 3, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 28, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 9, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 9, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 13, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 12, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |